Patient Selection
For patients who require spinal fusion to relieve pain and other symptoms caused by lumbar degenerative disc disease (DDD), the Infuse® Bone Graft/LT-Cage® Lumbar Tapered Fusion Device may be an appropriate treatment option.
Patient Selection
The Infuse® Bone Graft/LT-Cage® Lumbar Tapered Fusion Device is indicated for spinal fusion procedures in skeletally mature patients for the treatment of degenerative disc disease (DDD) at one level from L2-S1, who also may have Grade 1 spondylolisthesis or Grade 1 retrolisthesis at the involved level. Prior to surgery, patients should have been nonresponsive to at least 6 months of nonoperative therapy.
The Infuse Bone Graft/LT-Cage Lumbar Tapered Fusion Device should not be used in patients who:
- Are pregnant or who suspect they may be pregnant
- Are sensitive to titanium, titanium alloy, bovine Type I collagen or recombinant human bone morphogenetic protein-2 (rhBMP-2)
- Have an infection near the area of the surgical incision
- Have had a tumor removed from the area of the implantation site or currently have a tumor in that area
- Have bones that have not stopped growing
Last updated: 26 Feb 2013
